Maine Gov. Paul LePage said he’ll attend Donald Trump’s campaign rally in Bangor, Maine on Wednesday, the Portland Press Herald reports.
“I can’t wait to come up and help cheer him on in any way I can,” LePage told WVOM talk radio host Ric Tyler, according to the Press Herald.
LePage, the outspoken and oft-controversial governor, has endorsed Trump and appeared at Trump’s rally in Portland back in March. He said he expects a large crowd to hear the businessman’s speech in Bangor, which is Maine’s third-largest city.
“He’s a magnet for people—people love to listen to him. I look forward to seeing him,” LePage said. “He’s a personality of his own, as we all know, and I look forward to seeing him.”
Trump’s appearance is part of a bid to flip Maine to Republicans, even though the state last voted for a Republican presidential candidate in 1988. A poll from the Press Herald last week showed Hillary Clinton leading Trump 42 to 35 percent.
Last month, LePage said that he’d be open to joining Trump’s administration—if he was ambassador to Canada in the summer and Jamaica in the winter. He was also asked whether he might be selected as Trump’s vice president.
Even those who’ve come to expect the worst from Maine Gov. Paul LePage (R) were taken aback two weeks ago when he vetoed a bipartisan bill that would have allowed pharmacists to dispense an effective anti-overdose drug without a prescription. Making matters slightly worse was the Republican governor’s explanation.
“Naloxone does not truly save lives; it merely extends them until the next overdose,” LePage said in a written statement. As we discussed at the time, the governor, in a rather literal sense, made the case that those struggling with opioid addiction don’t have lives worth saving.
Experts from the health care and law enforcement communities hoped state lawmakers would override LePage’s veto. Late last week, the Portland Press Herald reported that the legislature did exactly that.
Maine lawmakers voted overwhelmingly Friday to override Gov. Paul LePage’s veto and allow pharmacists to dispense the drug overdose antidote naloxone without a prescription…. The House voted 132-14 and the Senate voted 29-5 to override LePage.
Also known by the brand name Narcan, naloxone works to quickly counteract the potentially deadly symptoms of an overdose from heroin or other opiates.
It’s worth noting for context that the Maine Senate has a Republican majority and the state House has a Democratic majority, though in this case, that didn’t make much of a difference.
As for the underlying policy, if anyone needs a refresher, Naloxone – sometimes known by its brand name, Narcan – is a safe and effective life-saving treatment that counteracts overdoses. The point is not to cure someone of an addiction, but rather, to prevent them from dying.
The treatment is inexpensive; it’s easy to administer; and it’s harmless to others. Common sense suggests it should be readily available, especially in areas where the addiction crisis is especially acute.
LePage, however, said he’s principally concerned with not “perpetuating the cycle of addiction.” If that means more of his constituents will overdose and die, so be it.
The Portland Press Herald reported two weeks ago that the state legislation was actually recommended by CVS, which received a letter from Sen. Angus King (I-Maine), himself a former governor, “asking the chain to expand the availability of the antidote. The bill got support from both law enforcement and health organizations during the legislative hearing.”
And now the policy will be state law, no thanks to Maine’s Tea Party governor.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.